Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique

被引:2
作者
Jessen, Neusa [1 ,2 ,3 ,4 ]
Sharma, Abhishek [2 ,5 ]
Jones, Jennifer [2 ,6 ,7 ]
Auala, Tangeni [2 ,8 ,9 ]
Boladuadua, Sainimere [2 ,10 ]
Jingi, Ahmadou [2 ,11 ]
Ferrer, Jose [2 ,12 ]
Mocumbi, Ana olga [2 ,13 ,14 ]
机构
[1] Univ Eduardo Mondlane, Fac Med, Ave Salvador Allende 702, Maputo, Mozambique
[2] World Heart Federat, Geneva, Switzerland
[3] Maputo Cent Hosp, Res Unit Dept Med, Maputo, Mozambique
[4] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique
[5] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Geneva, Boston, MA USA
[6] Natl Univ Ireland Galway, Galway, Ireland
[7] Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland
[8] Univ Cape Town, Cardiac Clin Div Cardiol, Cape Town, South Africa
[9] Windhoek Cent Hosp Complex, Div Adult Cardiol, Windhoek, Namibia
[10] Univ Auckland, Fac Med & Hlth Sci, Sch Med, Auckland, New Zealand
[11] Univ Yaounde, Yaounde, Cameroon
[12] Amer Heart Assoc Int, Dallas, TX USA
[13] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique
[14] Minist Saude, Inst Nacl Saude, Av Eduardo Mondlane, Caixa Postal 264, Maputo, Mozambique
关键词
essential medicines; cardiovascular medicines; cardiovascular diagnostics; Maputo; Mozambique; HEALTH; DRUGS; GAP;
D O I
10.5334/gh.1186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To tackle the increasing burden of non-communicable diseases (NCDs) and reduce premature cardiovascular (CV) mortality by a third by the year 2030, countries must achieve 80% availability of affordable essential medicines (EMs) and technologies in all health facilities.Objectives: To evaluate access to EMs and diagnostics for CV diseases in Maputo City, Mozambique.Methods: Using a modified version of World Health Organization (WHO)/Health Action International (HAI) methodology, we collected data on availability and price of 14 WHO Core EMs and 35 CV EMs in all 6 public-sector hospitals, 6 private-sector hospitals, and 30 private-retail pharmacies. Data on 19 tests and 17 devices were collected from hospitals. Medicine prices were compared with international reference prices (IRPs). Medicines were considered unaffordable if the lowest paid worker had to spend more than one day's wage to purchase a monthly supply.Results: Mean availability of CV EMs was lower than that of WHO Core EMs in both public (hospitals: 20.7% vs. 52.6%) and private sectors (retail pharmacies: 21.5% vs. 59.8%; hospitals: 22.2% vs. 50.0%). Mean availability of CV diagnostic tests and devices was lower in public (55.6% and 58.3%, respectively) compared to private sector (89.5% and 91.7%, respectively). Across WHO Core and CV EMs, the median price of lowest priced generic (LPG) and most sold generic (MSG) versions were 4.43 and 3.20 times the IRP, respectively. Relative to the IRP, median price of CV medicines was higher than that of Core EMs (LPG: 4.51 vs. 2.93). The lowest paid worker would spend 14.0 to 17.8 days' wage monthly to undergo secondary prevention.Conclusion: Access to CV EMs is limited in Maputo City owing to low availability and poor affordability. Public-sector hospitals are not well equipped with essential CV diagnostics. This data could inform evidence-based policies for improving access to CV care in Mozambique.
引用
收藏
页数:13
相关论文
共 32 条
  • [1] High-Cost Generic Drugs - Implications for Patients and Policymakers
    Alpern, Jonathan D.
    Stauffer, William M.
    Kesselheim, Aaron S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20) : 1859 - 1862
  • [2] [Anonymous], MED TERM STRAT PLAN
  • [3] [Anonymous], Global action plan for the prevention and control of noncommunicable diseases 20132020
  • [4] The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management
    Bowry, Ashna D. K.
    Lewey, Jennifer
    Dugani, Sagar B.
    Choudhry, Niteesh K.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (09) : 1151 - 1159
  • [5] The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion
    Bukhman, Gene
    Mocumbi, Ana O.
    Atun, Rifat
    Becker, Anne E.
    Bhutta, Zulfiqar
    Binagwaho, Agnes
    Clinton, Chelsea
    Coates, Matthew M.
    Dain, Katie
    Ezzati, Majid
    Gottlieb, Gary
    Gupta, Indrani
    Gupta, Neil
    Hyder, Adnan A.
    Jain, Yogesh
    Kruk, Margaret E.
    Makani, Julie
    Marx, Andrew
    Miranda, J. Jaime
    Norheim, Ole F.
    Nugent, Rachel
    Roy, Nobhojit
    Stefan, Cristina
    Wallis, Lee
    Mayosi, Bongani
    [J]. LANCET, 2020, 396 (10256) : 991 - 1044
  • [6] Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
    Cameron, A.
    Ewen, M.
    Ross-Degnan, D.
    Ball, D.
    Laing, R.
    [J]. LANCET, 2009, 373 (9659) : 240 - 249
  • [7] Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries
    Cameron, Alexandra
    Roubos, Ilse
    Ewen, Margaret
    Mantel-Teeuwisse, Aukje K.
    Leufkens, Hubertus G. M.
    Laing, Richard O.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2011, 89 (06) : 412 - 421
  • [8] Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
    Colgan, Sarah
    Faasse, Kate
    Martin, Leslie R.
    Stephens, Melika H.
    Grey, Andrew
    Petrie, Keith J.
    [J]. BMJ OPEN, 2015, 5 (12):
  • [9] Difvila J, 2008, URBANISATION MUNICIP
  • [10] Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases
    Ewen, Margaret
    Zweekhorst, Marjolein
    Regeer, Barbara
    Laing, Richard
    [J]. PLOS ONE, 2017, 12 (02):